The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III
- 1 January 2014
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 342 (1), 113-120
- https://doi.org/10.1016/j.canlet.2013.08.038
Abstract
No abstract availableKeywords
Funding Information
- Supporting Program of the “Twelfth Five-year Plan” for Science & Technology Research of China (2012ZX10002015-007)
- Key Program of the Shanghai Science and Technology Committee (10431903700)
- Shanghai Rising-Star Program (A type) (13QA1403300)
- National Natural Science Foundation (30901820)
- Specialized Research Fund for the Doctoral Program of Higher Education (20090073120109)
- State Key Laboratory of Oncogenes and Related Genes
This publication has 30 references indexed in Scilit:
- Combination of interferon-α and 5-fluorouracil induces apoptosis through mitochondrial pathway in hepatocellular carcinoma in vitroCancer Letters, 2011
- Growth Suppression of Human Hepatocellular Carcinoma Xenografts by a Monoclonal Antibody CH12 Directed to Epidermal Growth Factor Receptor Variant IIIJournal of Biological Chemistry, 2011
- EGFRvIII mRNA detection in the serum of patients with hepatocellular carcinomaLiver International, 2010
- Molecular targeted therapy for hepatocellular carcinomaThe Esophagus, 2009
- Bevacizumab plus 5-fluorouracil induce growth suppression in the CWR-22 and CWR-22R prostate cancer xenograftsMolecular Cancer Therapeutics, 2007
- Systemic Therapy of Advanced Hepatocellular Carcinoma: How Hopeful Should We Be?The Oncologist, 2006
- Les récepteurs à Epidermal Growth Factor (REGF), une nouvelle cible thérapeutiqueCancer/Radiothérapie, 2003
- Hepatocyte growth factor, transforming growth factor α, and their receptors as combined markers of prognosis in hepatocellular carcinomaMolecular Carcinogenesis, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer CellsJapanese Journal of Cancer Research, 1996